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Pharmacodynamic tolerance is believed to involve
homeostatic mechanisms initiated to restore normal
neural function. Drosophila exposed to a sedating dose
of an organic solvent, such as benzyl alcohol or ethanol,
acquire tolerance to subsequent sedation by that solvent.
The slo gene encodes BK-type Ca21-activated K1 channels
and has been linked to alcohol- and organic solvent-
induced behavioral tolerance in mice, Caenorhabditis
elegans (C. elegans) and Drosophila. The cyclic AMP
response element-binding (CREB) proteins are transcrip-
tion factors that have beenmechanistically linked to some
behavioral changes associated with drug addiction. Here,
we show that benzyl alcohol sedation alters expression of
both dCREB-A and dCREB2-b genes to increase produc-
tion of positively acting CREB isoforms and to reduce
expression of negatively acting CREB variants. Using
a CREB-responsive reporter gene, we show that benzyl
alcohol sedation increases CREB-mediated transcription.
Chromatin immunoprecipitation assays show that the
binding of dCREB2, with a phosphorylated kinase-induc-
ible domain, increases immediately after benzyl alcohol
sedation within the slo promoter region. Most impor-
tantly, we show that a loss-of-function allele of dCREB2
eliminates drug-induced upregulation of slo expression
and the production of benzyl alcohol tolerance. This
unambiguously links dCREB2 transcription factors to
these two benzyl alcohol-induced phenotypes. These
findings suggest that CREB positively regulates the
expression of slo-encoded BK-type Ca21-activated K1
channels and that this gives rise to behavioral tolerance
to benzyl alcohol sedation.
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Changes in the neural expression of the slo Ca2þ-activated Kþ
channel gene have been linked to the production of rapid drug
tolerance in the fly. It has been shown that benzyl alcohol
sedation induces neural expression of slo, that slo mutations
block the acquisition of behavioral tolerance and that trans-
genic induction of slo phenocopies the tolerant phenotype
(Cowmeadow et al. 2005; Ghezzi et al. 2004). However, the
molecular pathways that mediate the upregulation of slo
transcription are still unknown.
Previously, we have shown that sedationwith the anesthetic
benzyl alcohol produces a specific histone H4 hyperacetylation
pattern within the slo promoter region (Wang et al. 2007).
Histone acetylation is a common early step in gene activation.
Histone acetylation stimulates transcription because it loosens
the interaction between DNA and histones – making the DNA
more available for recognition by other transcription factors –
and because the bromodomains of a variety of general
transcription factors bind acetylated histones (Berger 2007).
The slo promoter region contains binding motifs for the
cyclic AMP (cAMP) response element-binding (CREB) protein
transcription factor. Cyclic AMP response element-binding
protein can recruit histone acetyltransferases to the promoter
region. In mammals, CREB is a key factor in producing
neuronal changes associated with drug tolerance and addic-
tion (Brunzell et al. 2003; McClung & Nestler 2003; Misra
et al. 2001; Widnell et al. 1996).
Two CREB gene family members, dCREB-A and dCREB2,
were discovered inDrosophilamore than a decade ago (Smolik
et al. 1992; Usui et al. 1993). Based on sequence similarity,
dCREB2 is thought to be the homolog of themammalian CREB
and cAMP response element modulator genes (Usui et al.
1993; Yin et al. 1995). In Drosophila, both the dCREB-A and the
dCREB2 genes are expressed in the adult brain (Smolik et al.
1992; Yin et al. 1995). dCREB-A has not yet been linked to
behavioral phenotypes; however, this may merely be because
appropriate mutant alleles have not yet been isolated. The
dCREB2 gene, which is also referred to as CrebB-17A in the
literature, has been shown to have a role in the production of
circadian rhythms, learning, memory and sexual behavior
(Belvin et al. 1999; Sakai & Kidokoro 2002; Yin et al. 1994).
dCREB2 transcripts are alternatively spliced. Most splice
variants have a consensus cAMP-dependent protein kinase A
(PKA) phosphorylation site (Ser-231, equivalent to Ser133 in
mammals) also known as the kinase-inducible domain, which
has been associated with CREB activation. In mammals, CREB
family members have been shown to work as positive and as
negative regulators of transcription (Lonze & Ginty 2002;
Shaywitz & Greenberg 1999). Furthermore, mammalian CREB
has been shown to stimulate transcription by recruiting the
histone acetylase CREB-binding protein (CBP) to the region and
by stabilizing the binding of other transcription factors at the
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promoter (Conkright et al. 2003; Ogryzko et al. 1996). In
Drosophila, the dCREB2-b splice variant has been shown to
be a negative regulator of CREB-mediated transcription. Other
dCREB2 splice variants are postulated to be activators of
transcription; however, not all investigators agree that dCREB2
activator isoforms exist (Perazzona et al. 2004; Yin et al. 1995).
Previously, we have shown that a CREB transcription factor
binds the slo promoter region using the chromatin immuno-
precipitation (ChromIP) assay. Overexpression of a dominant-
negative CREB (dCREB2-b) blocked benzyl alcohol-induced
histone acetylation within the slo promoter region, slo induc-
tion and drug tolerance (Wang et al. 2007). These data
were interpreted to mean that upregulation of the slo gene
represents a homeostatic response that counters the effects
of drug sedation and that CREB was likely to mediate slo
upregulation after benzyl alcohol sedation (Wang et al. 2007).
However, high-level expression of a dominant-negative tran-
scription factor could perturb gene expression in a way not
related to its normal function.
Here, we establish the function of CREB in the regulation of
slo expression and in the development of rapid tolerance as
produced by benzyl alcohol sedation. Using a reporter gene
assay, we show that benzyl alcohol sedation induces CREB-
stimulatedgeneexpressionand that thisappears tobemediated
by downregulation of a CREB repressor isoform. Furthermore,
we use a ChromIP assay to show that benzyl alcohol sedation
increases the occupancy of Ser-231-phosphorylated CREB in
the slo promoter region. Finally, we show that the dCREB2S162
mutant,which carries a premature stop codon in dCREB2 gene,
fails to develop the rapid benzyl alcohol tolerance phenotype
that has been associated with the slo gene expression.
Methods
Fly stocks
Drosophila stocks were Canton S (CS) (wild type), cAMP response
element (CRE)-luciferase transgenic flies (Iijima-Ando & Yin 2005) and
dCREB2S162/FM6 (Bloomington Stock Center, Indiana University,
Bloomington, IN, USA). The dCREB2S162 allele is a recessive mutation
in the dCREB2 gene (Belvin et al. 1999). It carries a C to T transition
that substitutes a stop codon for a glutamine in exon 7 just upstream
of the bZIP domain of the dCREB2 (Hendricks et al. 2001). To obtain
dCREB2S162 hemizygous flies, dCREB2S162/FM6 virgin females were
mated to CS males. As described previously, dCREB2S162 hemi-
zygous male escapers represent less than 1% of overall progeny
(Belvin et al. 1999). Flies stocks were raised on standard cornmeal/
molasses/agar medium and housed in a room with constant temper-
ature at 228C in a 12/12-h light and dark cycle. For the tolerance assay,
newly eclosed flies were collected over a 2- to 3-day window,
transferred to fresh food and studied 5–6 days after eclosed.
Tolerance assay
Age-matched and sex-matched flies were treated in triplicate with
benzyl alcohol (0.4%) or vehicle as described previously (Ghezzi et al.
2004). Each replicate contains 15 flies. Twenty-four hours later, both
treated and mock-treated control flies were simultaneously sedated
with benzyl alcohol (0.4%). Five minutes after sedation, flies were
transferred to an anesthetic-free tube for recovery, and snapshots of
the flieswere taken every 30 seconds during both the sedation and the
recovery stage. Flies were scored as recovered when they resumed
climbing. The number of recovered flieswas plotted as a percentage of
the population in each tube (average of three tubes) against time at
30-second intervals. The log-rank test was used to determine whether
the recovery time of the two populations differs significantly.
Luciferase reporter assay
The CRE-luciferase (CRE-luc) reporter gene construct is described in
Belvin et al. (1999). Briefly, the construct contains three copies of the
CRE (TGACGTCA) site followed by luciferase gene. This entire
cassette is flanked by insulator elements. Age-matched (4–6 days
old) CRE-luc females were separated into eight groups, each of which
contains 15 flies. Four groups of flies, 15 flies in each group, were
sedated with benzyl alcohol (0.4%), and the other four groups were
mock sedated. Four hours after sedation, flies from each group were
snap-frozen in liquid nitrogen and decapitated by vortexing the frozen
animals. The heads were collected by sieving and were homogenized
in cell lysis buffer (The Luciferase Assay System, E1500; Promega,
Madison, WI, USA), and debris were eliminated by spinning in a micro-
centrifuge. The luminescence in the cell lysis was measured using
Luciferase Assay System (E1500; Promega) with a luminometer
(Mithras LB 940; Berthold Technologies U.S.A. LLC, Oak Ridge, TN,
USA). Serial dilutions of cell lysate were used to confirm that the
measurements are in the linear range. Luciferase signals were
measured in triplicate and normalized with total protein concentration
in the extract. Protein concentrationwasmeasuredwith RCDCProtein
Assay kit (catalog number 500-0120; Bio-Rad, Hercules, CA, USA).
Chromatin immunoprecipitation
Three groups of flies, about 1500 flies in each group, were indepen-
dently sedated with benzyl alcohol, and three groups were indepen-
dently mock sedated. Four hours after benzyl alcohol sedation, fly
heads were collected from each group as described above. Heads
were cross-linked with 2% formaldehyde, and the ChromIP assay
was performed as described in Wang et al. (2007) using the anti-
phospho-dCREB2 antibody described in Horiuchi et al. (2004). This
antibody is specific for dCREB2 that is phosphorylated at Ser-231
(activated KID domain) and was used at 1:200 dilution. Both
co-immunoprecipitated and input DNA were recovered by reverse
cross-linking, phenol/chloroform extraction and ethanol precipitation.
Real-time polymerase chain reaction (PCR) was performed using the
ABI SYBR Green PCR protocol (Applied Biosystems, Foster City, CA,
USA) to determine the relative amount of DNA fragment from the slo
transcriptional control region that co-immunoprecipitated with phos-
pho-dCREB2. Within the slo transcriptional control region (Fig. 3a),
primers that were designed to amplify approximately 200-bp frag-
ments are C0 (50-ATCGAACGAAGCGTCCAG-30, 50-CGACGCGCT-
CAAACG-3 0) , 6b (5 0-CCAGCAGCAATTGTGAGAAA-3 0, 5 0-
CGAAGCAGACTTGAAAGCAA-30), cre1 (50-GATGGGAAAGCGAAAA-
GACAT-30, 50-CATGTCCGTCAAAGCGAAAC-30), S2 (50-CATTGC-
TATCCCTTCCCATC-30, 50-ATGCAATGAAGCGAAGAACC-30), 55b (50-
TACCCAATTGAATTCGCCTTGTCTT-3 0, 5 0-CCCACTCTCCGGC-
CATCTCT-30) and cre2 (50-TGGATTGCGACCGAGTGTCT-30, 50-AT-
CAATACGATAACT GGCGGAAACA-30). As a control, we used
pr imers for Cyc lophi l in 1 (Cyp1 ) p romoter region (5 0-
TCTGCGTATGTGTGGCTCAT-30, 50-TACAGAACTCGCGCATTCAC-30).
Each PCR reaction generated only the expected specific amplicon that
was proved by running the melting temperature profiles of the final
products (dissociation curve). The relative abundance of each co-
immunoprecipitate fragment (IP DNA) was expressed as a percentage
of the total amount of DNA fragment used in the immunoprecipitation
(input DNA) in both experiment and mock-sedated control with the
equation: IP/input ¼ 2(Ctinput  CtIP). Significance was determined with
the two-way analysis of variance. Independent repetitions of entire
procedure yielded essentially the same binding profile.
Real-time reverse transcriptase–PCR
Total RNA was extracted from the heads of three groups of
independently benzyl alcohol-sedated and three mock-treated groups
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of flies (15 flies per group). RNA was isolated 6 h after benzyl alcohol
sedation using a single-step RNA isolation protocol as described pre-
viously (Cowmeadow et al. 2006; Ghezzi et al. 2004) and quantified in
a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington,
DE, USA). Two-step reverse transcription and real-time PCR were
performed in triplicate with specific primers for dCREB-A, dCREB2-b,
slo C1 exon and Cyp1. Cyclophilin 1was used as an internal control gene
for normalization. First-strand complementary DNA (cDNA) was synthe-
sized from total RNAwith gene-specific reverse primerswith Superscript
II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The cDNA was
amplified by real-time PCR in an ABI Prism 7700 Sequence Detection
System (Applied Biosystems) using the ABI SYBR Green PCR protocol
(Applied Biosystems). Messenger RNA (mRNA) abundance was calcu-
lated using the standard-curve method (Applied Biosystems manual),
and significance was calculated using the Student’s t-test.
The followingprimerswereused toquantify the transcriptsof interest:
dCREB-A forward primer (50-TTCAACTACCTCAGCACCTATACGA-30),
dCREB-A reverse primer (50-TCTCGATGTCGGAGCAAATG-30),
dCREB2-b forward primer (50-ACTGCAGGTGGCAGTCCG-3 0),
dCREB2-b reverse primer (50-TAGACCACCTTCTGCATCGCT-30), slo
(C1) forward primer (50-AAACAAAGCTAAATAAGTTGTGAAAGGA-30)
and slo (C1) lower reverse primer (50-GATAGTTGTTCGTTCTTTT-
GAATTTGA-30). Transcripts from Cyp1 (internal control) were detected
using upstream primer 50-ACCAACCACAACGGCACTG-30 and the
downstream primer 50-TGCTTCAGCTCGAAGTTCTCATC-30.
Results
Expression of CREB mRNA is altered by
anesthetic sedation
To address the role of CREB in the production of tolerance,
we asked whether sedation altered expression of either of
the CREB genes. The dCREB-A transcription factor is thought
to be a positive regulator of transcription. Transcripts from the
dCREB2 gene are alternatively spliced. The dCREB2-b splice
variant has been clearly shown to be a repressor isoform with
important effects on behavior (Perazzona et al. 2004; Yin et al.
1995). We measured the relative abundance of dCREB-A and
dCREB2-b transcripts in fly heads by real-time reverse
transcriptase–PCR using message-specific primers. To
account for variability in RNA purification efficiency, the
abundance of CREB mRNA was expressed relative to the
abundance of mRNA from the Cyp1 gene. Cyclophilin 1
mRNA was chosen as an internal control because its abun-
dance was not affected by a single benzyl alcohol sedation
(Ghezzi et al. 2004). We observed that a single benzyl alcohol
sedation selectively upregulated the dCREB-A transcript and
downregulated the dCREB2-b splice variant. Based on these
changes, one would predict that benzyl alcohol sedation
produces a net increase in the abundance of the stimulatory
dCREB-A transcription factor and a net decrease in the
activity of the dCREB2-b negatively acting transcription factor
(Fig. 1). Thus, benzyl alcohol sedation is predicted to increase
CREB-stimulated gene transcription.
Sedation affects CRE-dependent gene expression
To test the hypothesis that sedation enhances CREB-
mediated transcription, we used the CRE-luc transgene to
compare the level of CREB-mediated gene expression before
and after sedation. In the CRE-luc transgene, a series of CREs
modulate expression of the bioluminescent luciferase
reporter gene. Expression of luciferase from this transgene
increases in response to activation by CREB (Iijima-Ando &
Yin 2005). The level of luciferase bioluminescence was
measured in lysates prepared from the heads of benzyl
alcohol-sedated and mock-sedated animals. Fly heads are
primarily composed of neural tissue and are easily isolated in
mass. Compared With mock-sedated animals, CRE-luc flies
showed a significant increase in bioluminescence 4 h after
a brief (15–30 min) benzyl alcohol sedation (Fig. 2). This
indicates that benzyl alcohol sedation resulted in an increase
in CREB-mediated transcription. Non-transgenic control
animals produced only trace levels of bioluminescence.
Figure 1: Benzyl alcohol (BA) sedation enhances dCREB-A
and reduces dCREB2 repressor splice variant (dCREB2-b)
mRNA abundance. The mRNA levels of CREB transcripts in fly
heads were measured using real-time reverse transcriptase–PCR
with Cyp1 as the internal control. RNA levels are normalized with
respect to untreated animals. Four hours after sedation with BA,
the dCREB-A messenger level was induced about 50% (n ¼ 11,
***P < 0.001, Student’s t-test). A single BA sedation causes
a reduction in the abundance of the dCREB2-b repressor isoform
(n ¼ 4, *P < 0.05, Student’s t-test).
Figure 2: Positive regulation by CREB increases after benzyl
alcohol (BA) sedation. CRE-luc transgenic flies were used to
measure CRE-dependent gene expression. The relative amount of
bioluminescence in fly head extractswasmeasured and normalized
to total protein (specific activity). Four hours after BA sedation,
luminescence activity was increased in CRE-luc transgenic flies
(n ¼ 4, *P < 0.05, Student’s t-test). Luciferase activity was not
detected in flies that did not contain the transgene (data not shown).
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Benzyl alcohol sedation increases the occupancy of
phosphorylated dCREB2 in the slo promoter region
The slo gene has been shown to be essential for the
acquisition of rapid benzyl alcohol tolerance. It has been
previously shown that benzyl alcohol sedation enhances the
binding of a CREB isoform, within the slo promoter region,
and that this binding is correlated with increased slo expres-
sion (Wang et al. 2007). However, the antibody used in the
prior experiment does not distinguish between dCREB-A and
dCREB2 products or between activated and non-activated
states. The kinase-inducible domain of CREB family members
becomes competent to stimulate transcription when it is
phosphorylated. Here, we performed the ChromIP assay
using an antibody specific for the phosphorylated kinase-
inducible domain of dCREB2 (Horiuchi et al. 2004). We
measured the relative occupancy of activated phosphorylated
dCREB2 at six positions across the slo transcriptional control
in chromatin isolated from fly heads. The relative abundance
of the co-immunoprecipitated genomic DNA was measured
by real-time PCR. We observed that benzyl alcohol sedation
increased phospho-dCREB2 occupancy at three sites known
to contain the DNA motif for a CRE site (cre1, 55b and cre2)
but not at positions that do not contain recognizable CRE sites
(C0, 6b, S2 and Cyp1). The ChromIP assay showed that
phospho-dCREB2 binds the slo promoter region and that the
binding of this form of activated CREB is enhanced by
sedation (Fig. 3).
A dCREB2 loss-of-function mutation blocks sedation-
induced slo induction
The slo gene is upregulated by benzyl alcohol sedation, and
increased slo expression is capable of producing the tolerant
phenotype. Previously, we had shown that overexpression of
the dCREB2-b repressor could block benzyl alcohol-induced
slo gene expression (Wang et al. 2007). To determine if
dCREB2 produces a positively acting factor that is required
for slo induction, we tested the response of animals carrying
the dCREB2S162 loss-of-function mutation. This mutant allele
carries a stop codon just upstream of the bZIP motif that
abolishes dCREB2 activity (Hendricks et al. 2001).
dCREB2S162 is homozygous lethal mutation that shows only
partial penetrance. We observed that less than 1% of hemi-
zygous dCREB2S162 males survived to adulthood, as
described previously (Belvin et al. 1999). These ‘escaper’
males are about three-fourths the size of wild-type flies but
appear healthy. Previous studies showed that dCREB2S162
escapermales have circadian arrhythmicity (Belvin et al. 1999).
If dCREB2 participates in drug-induced slo expression, then
the dCREB2S162 mutation should interfere with drug-evoked
enhancement of slo expression. To evaluate this idea, slo
transcripts were quantified 6 h after benzyl alcohol sedation
in both mutant dCREB2S162 flies and wild-type CS flies. In
dCREB2S162 males, slo mRNA levels decreased after benzyl
alcohol sedation (Fig. 4). As has been previously reported,
wild-type CS males showed a significant increase in slo
mRNA level 6 h after benzyl alcohol sedation (Ghezzi et al.
2004). This shows that benzyl alcohol-induced slo expression
is co-ordinated by the dCREB2 transcription factor.
A dCREB2 loss-of-function mutation eliminates the
capacity to acquire rapid tolerance
To determine if the dCREB2 gene produces a product that is
required for the development of drug tolerance, we examined
flies carrying the dCREB2S162 loss-of-function mutation. We
observed that a single benzyl alcohol sedation failed to induce
tolerance in dCREB2S162 hemizygous males. However, the
sibling FM6male flies (data not shown) andwild-type CSmale
(a)
(b)
Figure 3: Benzyl alcohol (BA) sedation enhances the occu-
pancy of activated CREB in the slo promoter region. (a) Map
of the transcriptional control region of the slo gene. The arrow-
heads indicate the transcription start sites of five tissue-specific
promoters. From left to right: the first two promoters are neural
specific, the next two are known to be active in epithelial cells of
the larval digestive tract and the rightmost promoter is responsi-
ble for tracheal and muscle cell expression. The labeled regions
below the line represent the position of blocks of sequence that
are evolutionarily conserved in the genus Drosophila. Conserved
control elements might regulate proximal and/or distal promoters
and cannot yet be determined solely by sequence analysis. This
map is not to scale but is drawn to align with the histogram. (b)
The relative abundance of phospho-CREB (pCREB) within the slo
promoter region was measured by ChromIP in fly heads 4 hours
after a BA sedation (black bars) and in control animals that have
never been sedated (gray bars). The antibody recognizes dCREB2
phosphorylated within the activation domain (position Ser-231).
The relative abundance of the co-immunoprecipitated genomic
DNAwasmeasured at six positions (C0, 6b, cre1, S2, 55b andcre2)
across the slo transcriptional control region by real-time PCR. We
also measured the relative abundance of a fragment from the
Cyp1 gene. This fragment is an internal control that does not
contain a CRE site andwhose expression is not upregulated by BA
treatment (Cowmeadow et al. 2005; Ghezzi et al. 2004). Signals
obtained from PCR amplification of immunoprecipitated chroma-
tin were normalized to the amount of input chromatin. Increased
pCREB occupancy was observed around three putative CRE sites
(cre1, cre2 and 55b). Significance was determined by two-way
analysis of variance (n ¼ 3, *P < 0.05). Error bars are SEM.
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flies can develop tolerance to the sedative effect of benzyl
alcohol after a single exposure (Fig. 5).
It is possible that the truncated polypeptide generated from
the dCREB2S162 allele might interfere with the capacity of the
flies to acquire tolerance in a dominant-negative manner
(Hendricks et al. 2001). To test this possibility, we measured
the ability of dCREB2S162/þ females to acquire tolerance.
Heterozygous flies can develop tolerance (Fig. 5), indicating
that the loss of tolerance is not because of a dominant
phenotype associated with the dCREB2S162 mutation.
We also noted another drug-related phenotype of the
dCREB2S162 mutants. At low concentrations, benzyl alcohol
acts as a stimulant. In wild-type animals, a hyperactive phase
precedes the sedative phase of benzyl alcohol exposure. This
short stimulatory period is thought to represent the time in
which the drug concentration within the fly is still relatively
low. We noted that the dCREB2S162 hemizygous males did
not exhibit a hyperactive phase in response to benzyl alcohol.
This most certainly is a consequence of low dCREB2 activity
during development because the speed of the response
precludes a role for changes in gene expression.
Discussion
Benzyl alcohol is an organic solvent that is used in dyes, inks
and cleaning solutions (Mookherjee & Wilson 1992). Most
organic solvents are potent central nervous system depres-
sants that produce sedation if inhaled or consumed in
sufficient quantities (Giovacchini 1985). These properties
have led to the use of organic solvents both as anesthetics
and as drugs of abuse. When flies are exposed to benzyl
alcohol, they first become hyperactive and then become
sedated, all within 10–15 minutes. It has been shown that
flies develop tolerance to benzyl alcohol sedation after a single
exposure to the drug (Ghezzi et al. 2004). Rapid tolerance to
benzyl alcohol sedation is dependent on the presence of
a functional slo gene (Ghezzi et al. 2004). The slo gene
encodes the BK-type calcium-activated potassium channel
(Adelman et al. 1992; Atkinson et al. 1991). In this study, we
use benzyl alcohol as a model organic solvent to study the
neuronal basis of rapid tolerance to organic solvents. Our
findings indicate that benzyl alcohol sedation increases CREB
signaling to upregulate the slo promoter activity, which gives
rise to rapid benzyl alcohol tolerance in flies.
Figure 4: The dCREB2S162 mutation blocks induction of slo
by benzyl alcohol (BA) sedation. slo mRNA levels in
dCREB2S162 (S162) and CS males were measured by real-time
reverse transcriptase–PCRwith primers specific for the neural slo
isoforms. Six hours after BA sedation, slomRNA decreased about
40% in the dCREB2S162 stock compared with non-treated group,
whereas BA sedation produced an increase in slo mRNA abun-
dance in the CS control group (n ¼ 4, *P < 0.05, Student’s t-test).
Figure 5: The dCREB2S162 mutation blocks the acquisition of
benzyl alcohol tolerance. (Top) Wild-type CS males acquire
rapid tolerance after a single benzyl alcohol sedation. (Middle)
Hemizygous dCREB2S162 males do not acquire tolerance after
one benzyl alcohol sedation. (Bottom) dCREB2S162 heterozygous
female flies acquire tolerance in response to prior benzyl alcohol
sedation. Significance between recovery curves was determined
by the log-rank test (n ¼ 45, *P < 0.05).
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A role for CREB in benzyl alcohol-induced responses was
indicated by the observation that benzyl alcohol sedation
enhanced expression from a CREB-responsive luciferase
transgene in fly heads. Furthermore, we observed that benzyl
alcohol sedation produces a rapid change in the abundance of
mRNAs produced from both CREB genes. The relative
abundance of dCREB-A transcript increased and the
abundance of dCREB2-b transcript dropped. The dCREB-A
transcription factor has been shown to activate transcription,
while dCREB2-b has been shown to be a dCREB2 splice
variant that acts as a transcriptional repressor. Both have
been shown to be expressed in the adult nervous system
(Smolik et al. 1992; Yin et al. 1995). An increase in the
abundance of a transcript encoding a CREB activator and
a reduction in the abundance of the transcripts encoding
a repressor isoform are predicted to cause a net increase in
expression from genes regulated by CREB. Both dCREB-A
and dCREB2 are expressed in the nervous system and may
contribute to the regulation of the slo gene. Because of the
availability of well-described mutant alleles in dCREB2, we
were able to directly test the role of dCREB2 in slo regulation.
A similar analysis cannot yet be performed for dCREB-A, and
it is possible that it also contributes transcription factors that
regulate slo gene expression.
In a previous study, we showed that expression of
a dCREB2-b dominant-negative transgene from a heat-shock
promoter could suppress benzyl alcohol-induced responses
including (1) histone acetylation changes across the slo pro-
moter region, (2) the induction of slo gene expression and (3)
the acquisition of tolerance to benzyl alcohol sedation (Wang
et al. 2007). This suggested that dCREB2 was involved in
regulating slo gene expression after sedation. However, over-
expression of a transcription factormight affect transcription of
genes not normally considered to be targets of its regulation.
To independently verify that dCREB2 plays a central role in
benzyl alcohol responses, we examined the phenotype of the
dCREB2S162 loss-of-function mutation (Belvin et al. 1999).
The loss of dCREB2 expression prevented both slo induction
and the acquisition of benzyl alcohol tolerance. This result
unambiguously links dCREB2 to these benzyl alcohol
responses. Benzyl alcohol sedation also causes a specific
pattern of histone acetylation changes across the slo pro-
moter region (Wang et al. 2007). We could not, however,
determine if the dCREB2S162 mutation affected this latter
benzyl alcohol-associated phenotype because it was not
possible to isolate a sufficient number (approximately 1000)
of hemizygous dCREB2S162 escaper males to perform the
ChromIP assay.
The hypothesis that dCREB2 regulates slo expression was
also supported by ChromIP assays performed using an
antibody raised against a phosphorylated dCREB2 kinase-
inducible domain (Horiuchi et al. 2004). Using this antibody,
we observed that benzyl alcohol sedation increased CREB
occupancy at the three CRE sites within the slo promoter
region. A product of the dCREB2 gene must be the entity
detected by this antibody because the dCREB-A gene does
not encode the hapten targeted by the antibody. Phosphor-
ylated kinase-inducible domains have been associated with
CREB isoforms that stimulate transcription (Shaywitz &
Greenberg 1999).
Cyclic AMP response element-binding protein activators
have been shown to promote gene expression through at
least three mechanisms. One mechanism is the binding of
the glutamine-rich Q2 domain of CREB to TAFII130, which is
a component of the transcription pre-initiation complex
(Ferreri et al. 1994; Quinn 1993). A second means of interact-
ing with TAFII130 is provided by the transducers of regulated
CREB activity (TORC) cofactors, which bind the bZIP domain of
CREB at one end and TAFII130 on the other end (Conkright
et al. 2003; Lonze & Ginty 2002). Both mammalian and
Drosophila genomes encode TORCs (Bittinger et al. 2004).
These interactions with TAFII130 may stimulate transcription
by stabilizing or modifying this transcription factor.
Phosphorylation of the kinase-inducible domain is not
thought to be required for gene activation by the latter two
mechanisms (Takemori & Okamoto 2008). However, CREB,
with a phosphorylated kinase-inducible domain, can stimulate
expression by binding the histone acetylase CBP. The resul-
tant acetylation of local histones makes the DNA more
accessible and enhances the affinity of the chromatin for
other transcription factors required for transcription (Brindle
et al. 1993; Gonzalez & Montminy 1989; Struhl 1998).
In mammals, phosphorylation of the kinase-inducible
domain is thought to be a major avenue through which cells
regulate CREB activity. In flies, however, most CREB activa-
tion domains exist in the phosphorylated active state
(Horiuchi et al. 2004). It is believed that flies make extensive
use of phosphorylation of CREB casein kinase sites in
the DNA-binding domain. Phosphorylation of casein kinase
sites inhibits the capacity of CREB to bind CRE sites (Horiuchi
et al. 2004). In flies, it has been proposed that modulation of
the capacity of CREB to bind its DNA element is the more
important aspect of the regulation of this transcription factor.
The protein expressed from the dCREB2-b splice variant is
a known transcriptional repressor. It is thought to repress
transcription by dimerizing with CREB activators and seques-
tering them in the cytoplasm or in the nucleus or by occupying
the CRE site to prevent their recognition by CREB activators
(Karpinski et al. 1992; Lonze & Ginty 2002; Shaywitz &
Greenberg 1999). While it is clear that dCREB2 can produce
a transcriptional repressor, it is controversial whether
dCREB2 also produces positively acting isoforms (Perazzona
et al. 2004; Yin et al. 1995). Nevertheless, our ChromIP data
show a correlation between phospho-dCREB2 binding (phos-
phorylated kinase-inducible domain) within the slo promoter
region and an induction in slo gene expression. This suggests
that either dCREB2 expresses activator isoforms that stimu-
late slo expression or phosphorylation of the kinase-inducible
domain prevents dCREB2-b repressor activity or causes it to
act as a transcriptional activator.
The slo gene has a well-described role in the response to
sedation with organic solvents (Cowmeadow et al. 2005,
2006; Davies et al. 2003; Ghezzi et al. 2004). We have shown
that the slo gene is a downstream target of the CREB
transcription factor, and we propose the following regulatory
cascade. A sedative dose of the anesthetic benzyl alcohol
activates the CREB pathway by downregulation of the CREB
repressor isoform. This frees up other CREB activator iso-
forms (probably dCREB2 isoforms), and the phosphorylated
versions of these proteins bind to CRE sites within the slo
6 Genes, Brain and Behavior (2009) doi: 10.1111/j.1601-183X.2009.00479.x
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promoter region and induce acetylation of the neighboring
histones. This increases availability of the underlying DNA and
increases the affinity of the promoter region for other required
transcription factors. These changes stimulate the neural-
specific promoters to increase the expression of BK-type
channel from the neural promoters. Increased BK channel
activity has been shown to act as a neural stimulant,
enhancing neural activity (Brenner et al. 2005). This regulatory
cascade is summarized in Fig. 6. We suspect that this change
directly counters some of the effects of the anesthetic on the
nervous system enabling the flies to recover more rapidly
from sedation – a behavioral phenotype that we classify as
benzyl alcohol tolerance.
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